Andlauer Healthcare Group Inc. (TSE:AND) Given Consensus Rating of “Moderate Buy” by Analysts

Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is C$48.57.

Several equities analysts have recently issued reports on AND shares. TD Securities boosted their price objective on Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Scotiabank boosted their price target on Andlauer Healthcare Group from C$43.00 to C$44.00 in a research report on Thursday, November 7th.

View Our Latest Research Report on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Performance

Shares of AND opened at C$42.84 on Friday. Andlauer Healthcare Group has a 1 year low of C$36.43 and a 1 year high of C$44.92. The company has a debt-to-equity ratio of 41.86, a quick ratio of 1.66 and a current ratio of 1.35. The company has a market cap of C$801.11 million, a price-to-earnings ratio of 28.18 and a beta of 0.66. The firm has a fifty day moving average of C$42.22 and a 200-day moving average of C$40.27.

Andlauer Healthcare Group Company Profile

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Further Reading

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.